Voya Financial Advisors, Inc. Novo Nordisk A S Transaction History

Voya Financial Advisors, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $623,216 - $780,724	-9,211 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$67.06 - $75.82 $377,413 - $426,714	-5,628 Reduced 37.93%	9,211 $626,000
Q4 2020 Mar 05, 2021	BUY	$63.89 - $73.8 $48,364 - $55,866	757 Added 5.38%	14,839 $1.04 Million
Q3 2020 Nov 16, 2020	BUY	$63.69 - $70.22 $28,596 - $31,528	449 Added 3.29%	14,082 $989,000
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $9,424 - $10,938	161 Added 1.2%	13,633 $894,000
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $50,004 - $65,492	1,011 Added 8.11%	13,472 $811,000
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $304,794 - $356,143	6,113 Added 96.3%	12,461 $719,000
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $4,326 - $4,862	91 Added 1.45%	6,348 $328,000
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $36,402 - $40,821	-778 Reduced 11.06%	6,257 $318,000
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $15,345 - $17,420	331 Added 4.94%	7,035 $366,000
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $4,984 - $5,670	120 Added 1.82%	6,704 $307,000
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $19,919 - $21,828	-426 Reduced 6.08%	6,584 $314,000
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $34,590 - $39,378	-781 Reduced 10.02%	7,010 $319,000
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $11,007 - $13,197	-227 Reduced 2.83%	7,791 $383,000
Q4 2017 Feb 14, 2018	SELL	$47.53 - $53.73 $3,422 - $3,868	-72 Reduced 0.89%	8,018 $431,000
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $332,903 - $398,189	8,090	8,090 $389,000

1,955

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Voya Financial Advisors, Inc. with notifications on news.